NCT04830176 is a NA clinical trial of dentifrice in Gingiva; Infection, sponsored by Ajman University.

Who is sponsoring NCT04830176?

NCT04830176 is sponsored by Ajman University.

What drugs are being tested in NCT04830176?

Interventions in NCT04830176: dentifrice.

What condition does NCT04830176 study?

NCT04830176 studies Gingiva; Infection, Plaque, Dental.

Is NCT04830176 still recruiting?

NCT04830176 is currently completed. Last updated 8 April 2021.

Last reviewed 2021-04-08 · How we verify

NCT04830176

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Role of Herbal Dentifrices in the Management of Plaque Induced Gingivitis

Completed NA Last updated 8 April 2021

What this trial tests

NA trial testing dentifrice in Gingiva; Infection in 30 participants. Completed in 28 March 2021.

Timeline

20 January 2021

Primary endpoint
20 March 2021

28 March 2021

Quick facts

Lead sponsor	Ajman University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	double
Primary purpose	prevention
Enrollment	30
Start date	20 January 2021
Primary completion	20 March 2021
Estimated completion	28 March 2021
Sites	1 location across India

Drugs / interventions tested

dentifrice — full drug profile →

Conditions studied

Gingiva; Infection — all drugs for Gingiva; Infection →
Plaque, Dental — all drugs for Plaque, Dental →

Sponsor

Ajman University

Who can join

Adults 20 to 60, any sex, with Gingiva; Infection or Plaque, Dental. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The clinical cross over study involves the use of two herbal based dentifirices moringa and miswak and its efficacy in reducing plaque induced gingivitis. The patients selected are provided with details regarding the research format and consent taken.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Antiplaque Efficacy of a Novel Moringa oleifera Dentifrice: A Randomized Clinical Crossover Study.
Duarte K, Thomas B, Varma SR, Kamath V, et al · · 2022 · cited 7× · PMID 35016231 · DOI 10.1055/s-0041-1736418

Verify or expand the search:

Other Ajman University trials

Trials by the same sponsor.

NCT07230717 — Evaluation of Pulpotomy Versus Pulpectomy in Primary Molars With Irreversible Pulpitis or Necrotic Pulp · NA · not yet recruiting
NCT06711263 — Role of Herbal Based Mouthwashes in Plaque Control · NA · not yet recruiting
NCT06554938 — Efficacy of Dental Hygiene Aids in Reducing Gingival Bleeding and Plaque Among Orthodontic Patients. · NA · completed
NCT06134713 — Effect of Intra-Canal Cryotherapy on Postoperative Pain After Endodontic Procedures · Phase 4 · unknown
NCT05931705 — Vit D Receptor Gene Polymorphism · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04830176 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ajman University
Last refreshed: 8 April 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04830176.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing